1. Introduction

Blood transfusions are lifesaving procedures. In dogs, because of the absence of naturally occurring alloantibodies, the risk of an acute hemolytic transfusion reaction at the first transfusion is negligible, but mismatched transfusions might produce alloimmunization. Safety of blood transfusion procedure depends on the knowledge of donor and recipient dog´s blood groups.

Dog blood group systems are defined according to species-specific antigens located on the surface of ered blood ythrocyte cell membranes and are defined according to antigenic recognition. Each individual might express an antigen to a varying degree (positive blood type) or don´t express a specific antigen (negative blood type)^[1][2] [1,2]. From the different blood groups systems reported in dogs, the Dog Erythrocyte Antigen (DEA) is the most studied with the DEA 1, 3, 4, 5, 6, 7 and 8 blood types recognized internationally after classification with polyclonal alloantibodies obtained from previously transfused dogs, or specific monoclonal antibodies^[1][3] [1,3]. Since they are inherited as a complex autosomal dominant allelic system, dog ered blood cellythrocytes might co-express any combination of these blood types on its surface ^[1][4][4,5]. Within the DEA blood group system, the DEA 1 has a strong antigenicity and results in blood incompatibility reactions. Formerly the DEA 1 was proposed to have three subtypes: DEA 1.1, DEA 1.2, and DEA 1.3, but it was demonstrated that a single monoclonal antibody can recognize these antigens that are expressed from strong to weak positivity. This level of expression is genetically determined and the expression pattern remains constant^[5][6] [5,6].

New dog blood groups have been described. The Dal blood type was initially described based on the identification of an acquired alloantibody in a Dalmatian dog^[7] [7]. A high percentage of Dal negative Dalmatians and Doberman pinchers have been reported in North America [8] and Germany^[8][9] [9]. More recently, an investigation on the prevalence of two new blood groups, Kai 1 and Kai 2, produced by mouse hybridoma techniques found that most dogs in North America were Kai 1 positive/Kai 2 negative [10]. There is no proved relationship between Dal, Kai and DEA blood groups^[10][11] [10,11]. The clinical relevance of Dal and Kai blood types in transfusion medicine is still unknown and testing is not currently routinely available. Blood incompatibilities related to other blood groups than DEA 1 can only be

evaluated by crossmatching ^[12].

Although dogs do not appear to have naturally occurring alloantibodies, and the first blood transfusion might be safe, a mismatched transfusions of DEA 1 positive to DEA 1 negative dogs produce anti-DEA 1 antibodies that might develop fatal, acute hemolytic reactions in subsequent incompatible transfusions^[12] [12]. Nonetheless, there is still controversy about the clinical importance of the naturally occurring alloantibodies against DEA blood types other than DEA 1. Knowledge of dog blood types after blood typing can prevent and minimize the risk of blood transfusion reactions and the induction of alloantibodies against red blood cellRBCs because of blood incompatibilities. Therefore, it is of utmost importance to know the prevalence of blood types in the diverse breeds and locations. For clinical purposes, DEA 1 negative dogs are considered the preferred blood donors^[4]. However, in dogs, although the DEA 1 antigen has been shown to be very antigenicand capable of eliciting a strong and long-lasting immune response, there is no evidence that alloimmunization occurs in 100% of incompatible transfusion episodes[4]. Therefore, caution should be exercised regarding the likelihood of a dog in the examined population developing alloimmunization and experiencing an acute hemolytic transfusion reaction following an incompatible DEA 1 transfusion.

Canine blood groups are known to vary between breeds and geographically^[13] [13]. For the most part, the prevalence of DEA 1 in canines is around 60%^[6] [6]. When looking to purebred dogs’, prevalences between 39.89% and 91.3% were found^[14] [14], and in mongrels it can vary from 42.8% in canine blood donors from Italy and Spain^[15] [15] to 91.3% in Brazil^[16] [16]. In the Sub-Saharan Africa DEA 1 prevalence can vary from 78% in Zimbabwe^[17] [17] to 47% in South Africa^[18] [18], and 39.89% in Nigeria [19].

This work determined the prevalence of DEA 1 blood type in a canine population of Luanda province of Angola, a country on the Sub-Saharan region of Africa, and assessed the risk of alloimmunization and blood transfusion reactions after an incompatible blood transfusion.

To our best knowledge, this is the first description of dog blood types in Angola (Southern Africa). The blood typing results, and demographic characteristics of the population tested are presented on table 1. The calculated probability that a dog will become sensitized following a first-time mismatched blood transfusion was 24.9% and the probability of an acute hemolytic reaction following a second incompatible blood transfusion was approximatly of 6.21%.

Table 1. Demographic characteristics and DEA 1 blood typing results of the dogs tested.

Demographic characteristics and blood typing results of the dogs tested.

In general, DEA 1 frequency was similar to that reported worldwide, but when compared to other Sub-Saharan African countries some differences were found. The risk of alloimmunization and acute hemolytic transfusion reactions in mismatched blood transfusions were higher than in other African regions. DEA 1 blood typing and/or crossmetching before blood transfusion is recommended. While blood typing tells us the blood group, crossmatching identifies blood incompatibilities that exist beyond the blood groups tested.

Also, results strongly support the idea that knowledge of breed blood types is helpful for building blood donor programs and recruiting donors during emergencies as well, especially if resources are limited for testing.

ThRe results, and outcomes here expressed should be carefully extrapolated to other geographic areaferences of Angola.

1. Hale, A.S. Canine blood groups and their importance in veterinary transfusion medicine. Vet Clin North Am Small Anim Pract 1995, 25, 1323– 32.
2. Giger, U. Blood typing and crossmathcing to ensure blood compatibility. In Kirk’s Current Veterinary Therapy; WB Saunders: St Louis, 2014; pp. 143–7.
3. Symons, M.; Bell, K. Canine blood groups: description of 20 specificities. Anim Genet 1992, 23, 509–15.
4. Hohenhaus, A.E. Importance of blood groups and blood type antibodies in companion animals. Trasfus Med Rev 2004, 18, 117–26.
5. Polak, K.; Acierno, M.M.; Raj, K.; Mizukami, K.; Siegel, D.L.; Giger, U. Dog erythrocyte antigen 1: mode of inheritance and initial characterization. Vet Clin Pathol 2015, 44, 369–79.
6. Acierno, M.M.; Raj, K.; Giger, U. DEA 1 expression on dog erythrocytes analyzed by immunocromatographic and flow cytometry techniques. J Vet Intern Med 2014, 28, 592-8.
7. Blais, M.-C.; Berman, L.; Oakley, D.A.; Giger, U. Canine dal blood type: a red cell antigen lacking in some Dalmatians. J Vet Intern Med 2007, 21, 281–6.
8. Goulet, S.; Giger, U.; Arsenault, J.; Abrams-Ogg, A.; Euler, C.C.; Blais, M.C. Prevalence and mode of inheritance of the dal blood Group in Dogs in North America. J Vet Intern Med 2017, 31, 751–8.
9. Ebelt, A.K.S.; Fuchs, S.; Weber, C.; Müller, E.; Giger, U. Survey of blood groups DEA 1, DEA 4, DEA 5, dal, and Kai1/Kai 2 in different canine breeds from diagnostic laboratory in Germany. Front Vet Sci, 2020, 7, 85.
10. Euler, C.C.; Lee, J.H.; Kim, H.Y.; Raj, K.; Mizukami, K.; Giger, U. Survey of two new (Kai 1 and Kai 2) and other blood groups in dogs of North America. J Vet Intern Med 2016, 30, 1642–7.
11. Proverbio, D.; Lubas, G.; Spada, E.; Medina Valentin, A.A.; Viñals Florez, L.M.; Del Rosario Perlado Chamizo, M.; Perego, R.; Pennisi, M.G.; Ferro, E.; Baggiani, L.; Gavazza, A.; Blais, M.C. Prevalence of Dal blood type and dog erythrocyte antigens (DEA) 1, 4, and 7 in canine blood donors in Italy and Spain. BMC Vet Res 2020, 16, 126.
12. Giger, U.; Gelens, C.J.; Callan, M.B.; Oakley, D.A. An acute hemolytic transfusion reaction caused by dog erythrocyte antigen 1.1 incompatibility in a previously sensitized dog. J Am Vet Med Assoc 1995, 206, 1358–62.
13. Arikan, S.; Guzel, M.; Mamak, N.; Oğrak, Y. Frequency of blood types DEA1.1, 3, 4, 5, and 7 in Kangal dog. Rev Med Vet 2009, 160, 180–3.
14. Mangiaterra, S.; Rossi, G.; Antognoni, M.T.; Cerquetella, M.; Marchegiani, A.; Miglio, A.; Gavazza, A. Canine Blood Group Prevalence and Geographical Distribution around the World: An Updated Systematic Review. Animals (Basel) 2021, 11, 342.
15. Proverbio, D.; Lubas, G.; Spada, E.; Medina Valentin, A.A.; Viñals Florez, L.M.; Del Rosario Perlado Chamizo, M.; Perego, R.; Pennisi, M.G.; Ferro, E.; Baggiani, L.; Gavazza, A.; Blais, M.C. Prevalence of Dal blood type and dog erythrocyte antigens (DEA) 1, 4, and 7 in canine blood donors in Italy and Spain. BMC Vet Res 2020, 16, 126.
16. Novais, A.A.; Santana, A.E.; Vicentin, L.A. Prevalence of DEA1 canine blood group system in dogs (Canis familiaris, Linnaeus, 1758) reared in Brazil. Braz J Vet Res Anim Sci 1999, 36, 23–7.
17. Dhliwayo, S.; Makonese, T.A.; Whittall, B.; Chikerema, S.M.; Pfukenyi, D.M.; Tivapasi, M.T. A study on the prevalence of dog erythrocyte antigen 1.1 and detection of canine Babesia by polymerase chain reaction from apparently healthy dogs in a selected rural community in Zimbabwe. J S Afr Vet Assoc 2016, 87, e1-e5.
18. van der Merwe, L.L.; Jacobson, L.S.; Pretorius, G.J. The breed prevalence of dog erythrocytes antigen 1.1 in the Onderstepoort area of South Africa and its significance in selection of canine blood donors. J S Afr Vet Ass 2002, 73, 53–6.
19. Nottidge, H.O.; Omobowale, T.O.; Washio, M.; Ajadir, A.; Toisumi, S.H.; Takahshi, K. The prevalence of the dog erythrocytre antigen (DEA 1.1 and DEA 1.2) in Nigerian indigenous dogs. Folia Vet 2006, 50, 66–8.